Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
3
×
life sciences
national blog main
san francisco blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
2019
activism
acute hepatic porphyria
aimmune therapeutics
akouos
allergy
alnylam pharmaceuticals
anaphylaxis
andrew oxtoby
astellas pharmaceuticals
bernie sanders
boston
What
drug
3
×
treat
3
×
approval
approved
fda
therapeutics
therapy
advanced
affects
agency
aimmune
allergy
alnylam’s
americans
awarded
bff
bio
conference
date
deals
developed
developing
devoted
disease
easl
form
frequency
friday
gene
hearing
immunotherapy
ipo
kicked
late
liver
loss
major
medicines
meds
millions
Language
unset
Current search:
treat
×
drug
×
" boston blog main "
×
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds
@xconomy.com
5 years ago
Bio Roundup: EASL Does It, Alnylam’s BFF, Gene Therapy Deals & More
